Fumitremorgin C alleviates advanced glycation end products (AGE)-induced chondrocyte inflammation and collagen II and aggrecan degradation through sirtuin-1 (SIRT1)/nuclear factor (NF)-κB/ mitogen-activated protein kinase (MAPK)

Yeli ZhouDepartment of Orthopedics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaView further author information

Jing LiDepartment of Orthopedics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaView further author information

Chenglong WangDepartment of Orthopedics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaView further author information

Zheer PanDepartment of Orthopedics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaCorrespondence[email protected]
View further author information

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.